Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
GNVC [NASD]
GenVec, Inc.
Index- P/E- EPS (ttm)-0.47 Insider Own6.10% Shs Outstand17.26M Perf Week3.57%
Market Cap30.03M Forward P/E- EPS next Y-0.43 Insider Trans2.33% Shs Float15.17M Perf Month-16.35%
Income-6.50M PEG- EPS next Q-0.11 Inst Own33.30% Short Float1.30% Perf Quarter-19.07%
Sales4.00M P/S7.51 EPS this Y29.40% Inst Trans-5.26% Short Ratio5.35 Perf Half Y-28.10%
Book/sh0.78 P/B2.23 EPS next Y-34.40% ROA-53.10% Target Price8.50 Perf Year2.35%
Cash/sh0.85 P/C2.06 EPS next 5Y35.00% ROE-70.40% 52W Range1.19 - 4.25 Perf YTD-25.00%
Dividend- P/FCF- EPS past 5Y24.60% ROI-223.90% 52W High-59.06% Beta2.15
Dividend %- Quick Ratio5.60 Sales past 5Y-24.50% Gross Margin- 52W Low46.22% ATR0.08
Employees11 Current Ratio5.60 Sales Q/Q-85.70% Oper. Margin- RSI (14)37.00 Volatility1.94% 4.17%
OptionableNo Debt/Eq0.00 EPS Q/Q58.30% Profit Margin- Rel Volume0.38 Prev Close1.71
ShortableYes LT Debt/Eq0.00 EarningsMar 28 BMO Payout- Avg Volume37.00K Price1.74
Recom2.00 SMA20-7.30% SMA50-14.79% SMA200-32.02% Volume14,125 Change1.75%
24-Feb-14Initiated HC Wainwright Buy $9
20-Oct-14 09:27AM  GENVEC INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
08:00AM  Zola P. Horovitz To Retire From GenVec Board PR Newswire
20-Aug-14 01:04PM  GENVEC INC Financials EDGAR Online Financials
12-Aug-14 09:42AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:30AM  GenVec Reports Second Quarter 2014 Financial Results PR Newswire
16-Jun-14 04:16PM  GENVEC INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits EDGAR Online
12-May-14 05:10PM  U.S./Canada daily earnings hits & misses May 12 - 1710 ET Reuters
09:31AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
08:03AM  GenVec sees FY14 cash burn between $5M-$7M at theflyonthewall.com
08:03AM  GenVec reports Q1 EPS (7c), one estimate 4c at theflyonthewall.com
08:00AM  GenVec Reports First Quarter 2014 Financial Results PR Newswire
28-Mar-14 03:02PM  GenVec's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
10:00AM  GenVec, Inc. Earnings Call scheduled for 10:00 am ET today CCBN
08:55AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:40AM  GenVec Reports Fourth Quarter and 2013 Year-End Financial Results PR Newswire
07:07AM  Q4 2013 GenVec, Inc. Earnings Release - Before Market Open CCBN
27-Mar-14 05:36PM  Why GenVec (GNVC) Stock Is Up In Aftermarket Trading at TheStreet +13.73%
21-Mar-14 08:00AM  GenVec To Release Fourth Quarter And Year-End 2013 Financial Results And Conduct A Conference Call On March 28, 2014 PR Newswire -5.90%
18-Mar-14 05:08PM  GENVEC INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
13-Mar-14 08:51AM  GenVec Announces $9 Million Registered Direct Offering PR Newswire -5.34%
03-Mar-14 08:00AM  GenVec to Present at 26th Annual ROTH Conference PR Newswire
26-Feb-14 07:31AM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
24-Feb-14 11:37AM  Coverage initiated on GenVec by HC Wainwright Briefing.com
13-Feb-14 06:15AM  GENVEC INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exh EDGAR Online
06:00AM  GenVec Achieves Third Milestone In Hearing And Balance Collaboration PR Newswire
03-Jan-14 07:00AM  3 Biotech Stocks Under $10 Triggering Breakouts at TheStreet
11-Dec-13 04:19PM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
27-Nov-13 09:40AM  GENVEC INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security EDGAR Online
12-Nov-13 09:52AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online -8.03%
07:50AM  GenVec Reports Third Quarter 2013 Financial Results PR Newswire
23-Oct-13 11:47AM  Online Auction for GenVec, Inc. Hosted by Surplus Solutions LLC and The Branford Group Business Wire
21-Oct-13 04:16PM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
07-Oct-13 04:15PM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
23-Sep-13 07:59AM  GenVec announces dismissal of class actoin lawsuit theflyonthewall.com +35.37%
07:59AM  InPlay: GenVec announces dismissal of class action lawsuit Briefing.com
07:58AM  GenVec Announces Dismissal Of Class Action Lawsuit PR Newswire
19-Sep-13 04:46PM  GENVEC INC Files SEC form 8-K, Shareholder Director Nominations EDGAR Online -9.68%
13-Sep-13 06:02PM  Nasdaq stocks posting largest volume increases AP +22.68%
05-Sep-13 04:42PM  GENVEC INC Files SEC form 8-K, Other Events, Regulation FD Disclosure EDGAR Online -10.42%
04-Sep-13 08:30AM  GenVec Board Restructures Operations and Withdraws Plan of Dissolution PR Newswire +77.78%
13-Aug-13 04:07PM  GENVEC INC Files SEC form 10-Q, Quarterly Report EDGAR Online -9.38%
08-Aug-13 05:27PM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
30-Jul-13 09:52AM  GENVEC INC Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online
28-Jun-13 09:49AM  GENVEC INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities EDGAR Online -5.13%
25-Jun-13 09:46AM  GENVEC INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf EDGAR Online +14.29%
24-Jun-13 09:51AM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
28-May-13 01:30AM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online -34.72%
10-May-13 09:10AM  GENVEC INC Files SEC form 10-Q, Quarterly Report EDGAR Online
26-Apr-13 02:22AM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
27-Mar-13 06:00PM  UK scientists develop safer foot-and-mouth vaccine at Reuters
22-Mar-13 05:51PM  GenVec Q4 Net Loss Deepens at Motley Fool
01:21PM  GenVec CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha
10:00AM  GenVec, Inc. Earnings Call scheduled for 10:00 am ET today CCBN
07:59AM  GenVec sees FY13 cash burn to be between $8M-$9M theflyonthewall.com
07:58AM  GenVec Reports Fourth Quarter And 2012 Year-End Financial Results PR Newswire
07:07AM  Q4 2012 GenVec, Inc. Earnings Release - Before Market Open CCBN
02:23AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
GenVec, Inc. operates as a biopharmaceutical company that uses differentiated and proprietary technologies to create therapeutics and vaccines. The company develops its product candidates through collaborations with various companies and organizations, including Novartis AG, Merial Limited, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of various human and animal health concerns. Its development programs address various therapeutic areas, such as hearing loss and balance disorders; and vaccines against infectious diseases, including respiratory syncytial virus, herpes simplex virus, dengue fever, and malaria. The company is also involved in developing vaccines against foot-and-mouth disease in the area of animal health. GenVec, Inc. was founded in 1992 and is based in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
EcoR1 Capital, LLC10% OwnerMay 27Buy2.399,04021,6201,024,358May 27 06:11 PM
EcoR1 Capital, LLC10% OwnerMay 23Buy2.194,60010,0951,019,696May 27 06:11 PM
EcoR1 Capital, LLC10% OwnerMay 22Buy2.1310,50022,3671,017,324May 27 06:11 PM
EcoR1 Capital, LLC10% OwnerMar 28Buy2.7347,515129,8491,176,907Mar 28 07:11 PM
EcoR1 Capital, LLC10% OwnerMar 27Buy2.4951,215127,6431,148,398Mar 28 07:11 PM
EcoR1 Capital, LLC10% OwnerMar 26Buy2.3123,54354,4901,117,669Mar 28 07:11 PM